Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Carcinoma, Merkel Cell × Cisplatin × Clear all

Phase

Status

Withdrawn 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 54 Squamous Cell Carcinoma of Head and Neck 31 Head and Neck Neoplasms 18 Urinary Bladder Neoplasms 17 Lung Neoplasms 16 Oropharyngeal Neoplasms 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Nasopharyngeal Carcinoma 11 Carcinoma 11 Uterine Cervical Neoplasms 8 Carcinoma, Transitional Cell 8 Carcinoma, Squamous Cell 8 Small Cell Lung Carcinoma 7 Pancreatic Neoplasms 7 Ovarian Neoplasms 7 Neoplasm Metastasis 7 Gallbladder Neoplasms 7 Breast Neoplasms 7 Triple Negative Breast Neoplasms 6 Neoplasms 6 Mouth Neoplasms 6 Melanoma 6 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Colorectal Neoplasms 6 Cholangiocarcinoma 6 Recurrence 5 Mesothelioma, Malignant 5 Medulloblastoma 5 Laryngeal Neoplasms 5

Interventions

avelumab 7 pembrolizumab 5 Nivolumab 5 Specimen Handling 3 Ipilimumab 3 Biopsy 3 cemiplimab 2 atezolizumab 2 Radiotherapy 2 Radiosurgery 2 Magnetic Resonance Spectroscopy 2 tocilizumab 1 talimogene laherparepvec 1 prednylidene 1 poly ICLC 1 lutetium Lu 177 dotatate 1 lenvatinib 1 flt3 ligand protein 1 durvalumab 1 deltacortene 1 Tacrolimus 1 Saline Solution 1 Radiation 1 Prednisone 1 Lutetium-177 1 Immunoglobulin G 1 Immune Checkpoint Inhibitors 1 Exercise Test 1 Exercise 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05594290 2026-01-14

MERCURY

Gruppo Oncologico del Nord-Ovest

Phase 2 Active not recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡